Association of allelic loss on 1q, 4p, 7q, 9p, 9q, and 16q with postoperative death in papillary thyroid carcinoma
- PMID: 10815903
Association of allelic loss on 1q, 4p, 7q, 9p, 9q, and 16q with postoperative death in papillary thyroid carcinoma
Abstract
Papillary thyroid carcinomas, most of which are characterized by slow growth and good prognosis, account for the majority of thyroid carcinomas. To provide appropriate postoperative management, it is important to classify them by prediction of their prognosis. To find genetic markers associated with poor prognosis, allelic loss at all 39 nonacrocentric chromosome arms was compared in 24 deceased cases and 45 age-, sex-, stage-, and type-matched survived cases. Allelic loss was examined in primary tumors from both groups using highly polymorphic microsatellite markers on 39 nonacrocentric autosomal arms. Age at diagnosis, sex, stage, and types of tumors were matched between the two groups. No recurrent tumor was used for DNA analysis. Mean fractional allelic loss in the deceased and survived cases was 0.10+/-0.08 and 0.03+/-0.05 (P < 0.001). The survived cases showed marginal frequencies of allelic loss throughout all chromosome arms except 22q. The deceased cases showed frequent allelic losses on chromosomes 1q (37%), 4p (21%), 7q (20%), 9p (36%), 9q (31%), and 16q (29%), with significant difference (P < 0.05). These chromosome regions may include tumor suppressor genes whose inactivation is associated with aggressive phenotypes of papillary thyroid carcinoma.
Similar articles
-
Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q.Genes Chromosomes Cancer. 2000 Mar;27(3):244-51. Genes Chromosomes Cancer. 2000. PMID: 10679913
-
Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.Clin Cancer Res. 2005 Oct 15;11(20):7226-33. doi: 10.1158/1078-0432.CCR-04-2597. Clin Cancer Res. 2005. PMID: 16243792
-
Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.Genes Chromosomes Cancer. 1998 Feb;21(2):131-43. Genes Chromosomes Cancer. 1998. PMID: 9491325
-
Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma.Genes Chromosomes Cancer. 2001 Sep;32(1):43-9. doi: 10.1002/gcc.1165. Genes Chromosomes Cancer. 2001. PMID: 11477660 Review.
-
Loss of heterozygosity in papillary and follicular thyroid carcinoma: a mini review.In Vivo. 2000 Jan-Feb;14(1):139-40. In Vivo. 2000. PMID: 10757070 Review.
Cited by
-
Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell.Mol Diagn Ther. 2019 Jun;23(3):369-382. doi: 10.1007/s40291-019-00387-0. Mol Diagn Ther. 2019. PMID: 30747408 Free PMC article.
-
Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis.Cancer Sci. 2020 Jun;111(6):2163-2173. doi: 10.1111/cas.14389. Epub 2020 Apr 16. Cancer Sci. 2020. PMID: 32187423 Free PMC article.
-
Tumor heterogeneity in a follicular carcinoma of thyroid: a study by comparative genomic hybridization.Endocr Pathol. 2011 Jun;22(2):103-7. doi: 10.1007/s12022-011-9154-y. Endocr Pathol. 2011. PMID: 21499728
-
Amplification of thymosin beta 10 and AKAP13 genes in metastatic and aggressive papillary thyroid carcinomas.Pathol Oncol Res. 2012 Apr;18(2):449-58. doi: 10.1007/s12253-011-9467-7. Epub 2011 Dec 11. Pathol Oncol Res. 2012. PMID: 22161024
-
Murine models and cell lines for the investigation of pheochromocytoma: applications for future therapies?Endocr Pathol. 2012 Mar;23(1):43-54. doi: 10.1007/s12022-012-9194-y. Endocr Pathol. 2012. PMID: 22323007 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical